The cannabis compound cannabidiol (CBD) “acts as neuroprotector in dopaminergic neurons, reducing neurotoxicity and α-syn accumulation highlighting its potential in the treatment of PD”, according to a new study.
The study is being published in the recent issue of the journal Neurochemical Research, and it was epublished online ahead of print by the National Library of Medicine. The research was conducted by investigators from the Universidade Federal de São Paulo, the Brazil National Institute for Translational Medicine and the University of São Paulo.
“Progressive neurodegenerative disorders such as Parkinson Disease (PD) lack curative or long-term treatments”, states the study’s abstract. “At the same time, the increase of the worldwide elderly population and, consequently, the extension in the prevalence of age-related diseases have promoted research interest in neurodegenerative disorders.”
Continue reading
House Bill 1478, “relating to the self-certification of an individual admitted into the hospice program for the medical use of marijuana”, was signed into law Thursday by Governor Burgum. The measure passed the House by a vote of 86 to 6, and it passed the Senate unanimously, 45 to 0.
Although the total number of marijuana sales is up from last January, it’s down 7% from December. Sales in December reached a monthly record of CA$425.9 million. This is according to data released by Statistics Canada.
Senate Bill 1 was passed by the state’s Senate in January by a vote of 20 to 15 and was approved by the House of Representatives in a 36 to 32 vote earlier this month, with some minor amendments. The Senate then voted 19 to 15 to concur on amendments, sending it to Governor Noem.
Conducted by Research and Markets, the report found that as of the start of 2023, the global marijuana-infused edibles market is worth $5.14 billion. It’s expected to grow at an annual compound growth rate (CAGR) of 12.26% between now and 2028 to reach a value of $9.28 billion.
“In enacting this bill, it is the intent of the legislature to authorize the use of medical cannabis for persons diagnosed with a substantial health condition”, states House Bill 370, filed by Republican State Representative John Vander Woude (who is Chair of the House Health and Welfare Committee ). The measure is titled the Idaho Medical Cannabis Act.
For the study researchers from Washington State University and Legacy Research Institute in Portland examined the efficacy and safety profile of vaporized CBD in female rates. They found that rats provided with CBD were less likely to self-administer morphine.
